Clinical Studies
Breast Care
Cardiology
Colon Cancer
Dermatology
Diabetes
Gastrointestinal
HIV/AIDS
Mental Health
Neurology
Obesity/Weight Management
Women's Health
Other
Special Features
Advances/Research
Chronic Hepatitis B Virus (HBV) Infection
| Principal Investigator: | Albert Min, MD | |
| Time frame of study: | January 2007 – January 2017 | |
| Time frame of participation: | Up to 10 years | |
| Number of participants needed: | Open | |
| Location of Study: | Phillips Ambulatory Care Center 10 Union Square East New York, NY 10003 |
|
| Contact Name, Number & Email: | Sr. Clinical Research Coordinator Ivanka Zic, RN, MSN, CCRC (212) 844-6408 izic@chpnet.org or Clinical Research Coordinator Sarah Medina, MD, CRC samedina@chpnet.org |
Summary:
The Division of Digestive Diseases is conducting a clinical
study to assess the long-term outcomes (benefits and risks) associated
with entecavir (ETV) therapy as compared to other hepatitis B medication
approved for the treatment of chronic HBV infection.
Criteria for
Participation:
• Patients must be at least 18 years of
age
• Have chronic hepatitis B infection
• Not be co-infected with HIV
• Have never been treated with entecavir
• Not be pregnant or breast-feeding